Learn how we’ve supported neurology clinical trials, globally
Highlights include:
- 160% randomized at -32% cost per patient, for early Alzheimer’s in 5 countries
- 1 in 3 referrals randomized for a virtual severe dementia study
- Increased trial enrollment by 200% for a Phase II migraine trial
